vs
Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $148.5M, roughly 1.0× OPKO HEALTH, INC.). On growth, STURM RUGER & CO INC posted the faster year-over-year revenue change (3.6% vs -19.2%). STURM RUGER & CO INC produced more free cash flow last quarter ($12.3M vs $-28.6M). Over the past eight quarters, STURM RUGER & CO INC's revenue compounded faster (5.1% CAGR vs -7.5%).
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
OPK vs RGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.5M | $151.1M |
| Net Profit | $-31.3M | — |
| Gross Margin | 43.1% | 17.8% |
| Operating Margin | -25.8% | 2.3% |
| Net Margin | -21.1% | — |
| Revenue YoY | -19.2% | 3.6% |
| Net Profit YoY | -322.8% | — |
| EPS (diluted) | $-0.04 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.5M | $151.1M | ||
| Q3 25 | $151.7M | $126.8M | ||
| Q2 25 | $156.8M | $132.5M | ||
| Q1 25 | $150.0M | $135.7M | ||
| Q4 24 | $183.6M | $145.8M | ||
| Q3 24 | $173.6M | $122.3M | ||
| Q2 24 | $182.2M | $130.8M | ||
| Q1 24 | $173.7M | $136.8M |
| Q4 25 | $-31.3M | — | ||
| Q3 25 | $21.6M | $1.6M | ||
| Q2 25 | $-148.4M | $-17.2M | ||
| Q1 25 | $-67.6M | $7.8M | ||
| Q4 24 | $14.0M | — | ||
| Q3 24 | $24.9M | $4.7M | ||
| Q2 24 | $-10.3M | $8.3M | ||
| Q1 24 | $-81.8M | $7.1M |
| Q4 25 | 43.1% | 17.8% | ||
| Q3 25 | 32.9% | 15.1% | ||
| Q2 25 | 31.5% | 3.9% | ||
| Q1 25 | 28.4% | 22.0% | ||
| Q4 24 | 46.1% | 22.8% | ||
| Q3 24 | 23.1% | 18.5% | ||
| Q2 24 | 28.4% | 22.3% | ||
| Q1 24 | 24.2% | 21.5% |
| Q4 25 | -25.8% | 2.3% | ||
| Q3 25 | 31.7% | -2.7% | ||
| Q2 25 | -38.3% | -15.6% | ||
| Q1 25 | -44.8% | 6.2% | ||
| Q4 24 | -18.0% | 7.8% | ||
| Q3 24 | 8.2% | 3.1% | ||
| Q2 24 | -33.9% | 6.9% | ||
| Q1 24 | -41.2% | 5.5% |
| Q4 25 | -21.1% | — | ||
| Q3 25 | 14.3% | 1.2% | ||
| Q2 25 | -94.7% | -13.0% | ||
| Q1 25 | -45.1% | 5.7% | ||
| Q4 24 | 7.6% | — | ||
| Q3 24 | 14.3% | 3.9% | ||
| Q2 24 | -5.7% | 6.3% | ||
| Q1 24 | -47.1% | 5.2% |
| Q4 25 | $-0.04 | $0.22 | ||
| Q3 25 | $0.03 | $0.10 | ||
| Q2 25 | $-0.19 | $-1.05 | ||
| Q1 25 | $-0.10 | $0.46 | ||
| Q4 24 | $0.02 | $0.62 | ||
| Q3 24 | $0.03 | $0.28 | ||
| Q2 24 | $-0.01 | $0.47 | ||
| Q1 24 | $-0.12 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $364.4M | $92.5M |
| Total DebtLower is stronger | $344.0M | — |
| Stockholders' EquityBook value | $1.3B | $283.8M |
| Total Assets | $1.9B | $342.0M |
| Debt / EquityLower = less leverage | 0.27× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $364.4M | $92.5M | ||
| Q3 25 | $412.0M | $80.8M | ||
| Q2 25 | $267.3M | $101.4M | ||
| Q1 25 | $428.8M | $108.3M | ||
| Q4 24 | $426.6M | $105.5M | ||
| Q3 24 | $400.1M | $96.0M | ||
| Q2 24 | $40.6M | $105.6M | ||
| Q1 24 | $75.6M | $115.3M |
| Q4 25 | $344.0M | — | ||
| Q3 25 | $344.2M | — | ||
| Q2 25 | $343.3M | — | ||
| Q1 25 | $439.2M | — | ||
| Q4 24 | $437.2M | — | ||
| Q3 24 | $441.0M | — | ||
| Q2 24 | $201.9M | — | ||
| Q1 24 | $350.1M | — |
| Q4 25 | $1.3B | $283.8M | ||
| Q3 25 | $1.3B | $279.6M | ||
| Q2 25 | $1.3B | $289.3M | ||
| Q1 25 | $1.3B | $321.5M | ||
| Q4 24 | $1.4B | $319.6M | ||
| Q3 24 | $1.4B | $314.9M | ||
| Q2 24 | $1.4B | $321.5M | ||
| Q1 24 | $1.3B | $332.0M |
| Q4 25 | $1.9B | $342.0M | ||
| Q3 25 | $2.0B | $342.3M | ||
| Q2 25 | $2.0B | $349.5M | ||
| Q1 25 | $2.1B | $379.0M | ||
| Q4 24 | $2.2B | $384.0M | ||
| Q3 24 | $2.3B | $373.5M | ||
| Q2 24 | $2.0B | $376.7M | ||
| Q1 24 | $2.0B | $385.0M |
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.9M | $15.5M |
| Free Cash FlowOCF − Capex | $-28.6M | $12.3M |
| FCF MarginFCF / Revenue | -19.3% | 8.2% |
| Capex IntensityCapex / Revenue | 1.8% | 2.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-190.8M | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.9M | $15.5M | ||
| Q3 25 | $-34.6M | $12.9M | ||
| Q2 25 | $-83.4M | $14.7M | ||
| Q1 25 | $-34.6M | $11.1M | ||
| Q4 24 | $-44.4M | $20.0M | ||
| Q3 24 | $-77.1M | $9.4M | ||
| Q2 24 | $-26.4M | $18.7M | ||
| Q1 24 | $-35.6M | $7.3M |
| Q4 25 | $-28.6M | $12.3M | ||
| Q3 25 | $-37.8M | $7.0M | ||
| Q2 25 | $-86.7M | $9.1M | ||
| Q1 25 | $-37.7M | $10.0M | ||
| Q4 24 | $-49.8M | $16.4M | ||
| Q3 24 | $-85.0M | $2.6M | ||
| Q2 24 | $-33.7M | $10.1M | ||
| Q1 24 | $-40.0M | $5.6M |
| Q4 25 | -19.3% | 8.2% | ||
| Q3 25 | -24.9% | 5.5% | ||
| Q2 25 | -55.3% | 6.9% | ||
| Q1 25 | -25.2% | 7.4% | ||
| Q4 24 | -27.1% | 11.2% | ||
| Q3 24 | -49.0% | 2.1% | ||
| Q2 24 | -18.5% | 7.7% | ||
| Q1 24 | -23.0% | 4.1% |
| Q4 25 | 1.8% | 2.1% | ||
| Q3 25 | 2.1% | 4.6% | ||
| Q2 25 | 2.1% | 4.2% | ||
| Q1 25 | 2.1% | 0.8% | ||
| Q4 24 | 2.9% | 2.5% | ||
| Q3 24 | 4.6% | 5.5% | ||
| Q2 24 | 4.0% | 6.6% | ||
| Q1 24 | 2.6% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | -1.60× | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | -3.17× | — | ||
| Q3 24 | -3.10× | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
